To unravel the complexity of CKD, multi-disciplinary research is crucial! The research carried out by our Strategy-CKD consortium will focus on the gut-kidney axis, with a particular focus on the intestinal microbiome. 🔬 (3/4)
Is gut microbiota a hidden driver of chronic kidney disease❓🤔
EU researchers at @StrategyCKD explore how it influences cardiovascular risks, paving the way for innovative treatments. Learn more: 👉 https://t.co/GR7pifQPvP
EKHA President @RaymondVanhold1 was at the #EACH event today to highlight the many links between heart disease and kidney disease and the value of Albuminuria screening to identify patients at risk of both #CVD and #CKD.
🙏A big thanks to @EUCVHAlliance for the opportunity.
Amazing week at @ASNKidney#KidneyWk 2024 in San Diego, it was an incredible experience! Grateful for the support that made this trip possible. It was inspiring to connect with colleagues in the #KidneyStarts group specially @XiaoboSun_Mayo and #BrennanWinkler!
🎓 Ravi d'avoir présenté mon expérience de #thèse au Séminaire #Recherche SFNDT/CUEN vendredi dernier! Un grand merci pour cette belle opportunité. J'espère avoir motivé des jeunes néphrologues à poursuivre la recherche! @com_SFNDT@C_U_E_N@StrategyCKD
Exciting update from our colleagues @SonnalLohia and Sophie! Their latest research paper investigates the human gut-kidney axis by faecal proteomics and highlights molecular mechanisms affected in CKD.🔬#ckd#strategyckd#kidney@HeliyonJournal
Read more:
https://t.co/uO6ptkwJAa
Many congratulations to Dr. @SonnalLohia for defending her thesis titled “Peptidomic analysis to investigate the pathophysiology of chronic diseases” and obtaining her PhD in Theoretical Medicine from @RWTH Aachen 🇩🇪. We are all very proud of you 👏🏻
Revitalizing the Gut Microbiome in Chronic Kidney Disease: A Comprehensive Exploration of the Therapeutic Potential of Physical Activity https://t.co/LpKRbVp1F0 #mdpitoxins via @Toxins_Mdpi
Exciting update from our colleague Chiara (@Hospital_FJD) ! Her research shows that butyrate promotes kidney resilience to acute kidney injury and decreases inflammation by preventing downregulation of kidney protective genes such as klotho.
Read more:
https://t.co/sVUBtoD1iv
🎉Exciting news! The virtual doors of the STRATEGY-CKD museum are now open! Don’t miss out! Explore now: https://t.co/zKUQ8EdNig
#HorizonEU#ckd#MSCActions
Today we celebrate #WorldKidneyDay! Let's mark the day by advocating for #KidneyHealthForAll! Share your activity with us, tag us on your social media posts, and we will be thrilled to share it on our social media channels! https://t.co/5alA8GgJH4 @ISNkidneycare@ifkf_wka
#DYK? #CKD affects over 850 million people globally.
Therapeutic #innovation can prevent #ChronicKidneyDisease, but access to therapies is inequitable. On #WorldKidneyDay let’s advocate for #kidneycare for all, in the EU and beyond. It’s time to save kidneys, hearts, and lives!
Concluding our final STRATEGY-CKD consortium meeting in Prague 🇨🇿 on a high note! We delved deep into our last results, engaged in many scientific discussions, and, though bittersweet, shared heartfelt goodbyes. #ckd#horizon2020#MSCActions#chronickidneydisease#networking
Are you looking to apply Large Language Models to biomedical questions? You may want to take a look at our new framework (https://t.co/CY8x9n1n9p) and the updated preprint (https://t.co/IZrXmgFHNy). 🧵👇
Do you want to discover how organs on a chip can be used to study #CKD and how can they be adapted to study the effects of #microbiota metabolites on the #kidneys?
Then check our latest Draw my PhD video about @lauragiordn (ESR 11) work!
#research#wkd#DrawmyPhD
Many congratulations to Dr.Chiara Favero (ESR7) for defending her thesis titled “Butyrate treatment for acute kidney injury” and receiving her PhD in Pharmacology and Physiology. The entire consortium is very proud of you Chiara! #ckd#strategyckd#horizoneurope @uammadrid
Congratulations to Dr. Yuselys Garcia Martinez(ESR8) for defending her thesis "Sulfur Metabolic Alterations in CKD: Unravelling the impact of Gut Microbiota Dysbiosis and Uremic Toxicity" and obtaining the PhD in Clinical and Experimental Medical Sciences.Well Done👏@unicampania